Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86,803 | 77,086 | 52,205 | 79,311 | 131,296 |
| Receivables | 145,571 | 151,607 | 132,241 | 125,465 | 134,546 |
| Inventories | 220,442 | 221,978 | 211,429 | 213,878 | 241,835 |
| Income taxes - deferred | N/A | N/A | N/A | 46,897 | 58,173 |
| TOTAL | $493,986 | $494,565 | $438,495 | $504,912 | $608,247 |
| Non-Current Assets | |||||
| PPE Net | 208,648 | 210,330 | 205,181 | 197,200 | 215,460 |
| Intangibles | 1,097,592 | 1,110,959 | 1,116,129 | 1,112,147 | 797,605 |
| Other Non-Current Assets | 13,936 | 14,408 | 14,419 | 13,361 | 16,582 |
| TOTAL | $1,320,176 | $1,335,697 | $1,335,729 | $1,322,708 | $1,029,647 |
| Total Assets | $1,814,162 | $1,830,262 | $1,774,224 | $1,827,620 | $1,637,894 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 2,903 |
| Accounts payable and accrued liabilities | 43,954 | 53,993 | 34,772 | 38,587 | 58,197 |
| Accrued Expenses | 76,472 | 77,602 | 84,314 | 85,491 | 82,850 |
| TOTAL | $149,827 | $156,630 | $139,127 | $139,947 | $155,753 |
| Non-Current Liabilities | |||||
| Long Term Debt | 461,250 | 491,563 | 481,875 | 502,188 | 429,375 |
| Deferred Revenues | 8,151 | 7,222 | 5,666 | 4,931 | 4,303 |
| Other Non-Current Liabilities | 251,961 | 249,233 | 246,888 | 245,878 | 246,342 |
| TOTAL | $869,548 | $897,245 | $883,654 | $957,573 | $770,418 |
| Total Liabilities | $1,019,375 | $1,053,875 | $1,022,781 | $1,097,520 | $926,171 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 74,721 | 74,438 | 74,001 | 73,965 | 66,327 |
| Common Shares | 462 | 460 | 917 | 458 | 420 |
| Retained earnings | 172,052 | 157,563 | 145,879 | 128,038 | 328,341 |
| Other shareholders' equity | -43,697 | -36,786 | -48,023 | -41,844 | -40,409 |
| TOTAL | $794,787 | $776,387 | $751,443 | $730,100 | $711,723 |
| Total Liabilities And Equity | $1,814,162 | $1,830,262 | $1,774,224 | $1,827,620 | $1,637,894 |